MA40375A1 - Human antibodies against influenza hemagglutinin - Google Patents
Human antibodies against influenza hemagglutininInfo
- Publication number
- MA40375A1 MA40375A1 MA40375A MA40375A MA40375A1 MA 40375 A1 MA40375 A1 MA 40375A1 MA 40375 A MA40375 A MA 40375A MA 40375 A MA40375 A MA 40375A MA 40375 A1 MA40375 A1 MA 40375A1
- Authority
- MA
- Morocco
- Prior art keywords
- influenza hemagglutinin
- human antibodies
- antibodies against
- against influenza
- antibodies
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title abstract 3
- 101710154606 Hemagglutinin Proteins 0.000 title abstract 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title abstract 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title abstract 2
- 101710176177 Protein A56 Proteins 0.000 title abstract 2
- 239000000185 hemagglutinin Substances 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne des anticorps monoclonaux, ou des fragments liant l'antigène de ceux-ci, qui se lient à la protéine hémagglutinine de la grippe (ha), des compositions pharmaceutiques comprenant les anticorps et des procédés d'utilisation. Les anticorps de l'invention sont utiles pour inhiber ou neutraliser l'activité du virus de la grippe, et fournissent ainsi un moyen de traitement ou de prévention d'une infection grippale chez les humains. Dans certains modes de réalisation, l'invention cThe present invention relates to monoclonal antibodies, or antigen-binding fragments thereof, which bind to influenza hemagglutinin protein (ha), pharmaceutical compositions comprising antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing the activity of the influenza virus, and thus provide a means for treating or preventing an influenza infection in humans. In some embodiments, the invention c
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094752P | 2014-12-19 | 2014-12-19 | |
| PCT/US2015/066654 WO2016100807A2 (en) | 2014-12-19 | 2015-12-18 | Human antibodies to influenza hemagglutinin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA40375A1 true MA40375A1 (en) | 2018-06-29 |
| MA40375B1 MA40375B1 (en) | 2019-09-30 |
Family
ID=58672203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA40375A MA40375B1 (en) | 2014-12-19 | 2015-12-18 | Human antibodies against influenza hemagglutinin |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR103054A1 (en) |
| MA (1) | MA40375B1 (en) |
-
2015
- 2015-12-16 AR ARP150104113A patent/AR103054A1/en not_active Application Discontinuation
- 2015-12-18 MA MA40375A patent/MA40375B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA40375B1 (en) | 2019-09-30 |
| AR103054A1 (en) | 2017-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791086A1 (en) | HUMAN ANTIBODIES AGAINST HEMAGGLUTININ VIRUS OF FLU | |
| MA44312A (en) | ANTIBODIES AND THEIR METHODS OF USE | |
| MA40041B1 (en) | Anti-gitr antibodies and methods of use thereof | |
| EA201791675A1 (en) | HUMAN ANTIBODIES TO GLOBOPROTEIN OF EBOL VIRUS | |
| WO2018069500A3 (en) | ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS | |
| BRPI0821110B8 (en) | anti-nr10/il31ra neutralizing antibody, pharmaceutical composition comprising said antibody and use thereof | |
| WO2012021786A3 (en) | Anti-hemagglutinin antibody compositions and methods of use thereof | |
| BR112022003956A2 (en) | anti-cd73 antibodies | |
| PH12018502673A1 (en) | Anti-zika virus antibodies and methods of use | |
| MA40913A (en) | ANTIBODY-DRUG CONJUGATES | |
| MA55868A (en) | ANTI-CTLA4 MONOCLONAL ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EA200800355A1 (en) | NEUTRALIZING HUMAN ANTIBODIES AGAINST B7RP1 | |
| MX381232B (en) | FORMULATION OF ANTIBODY. | |
| MX2017001976A (en) | Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1. | |
| MX2022005256A (en) | CD73 INHIBITORS. | |
| MX2020008736A (en) | FORMULATIONS OF B7-H4 ANTIBODIES. | |
| MA39342B2 (en) | Il -21 antibody | |
| EA201990988A1 (en) | ANTIBODIES AGAINST CHIKV AND WAYS OF THEIR APPLICATION | |
| PH12020551051A1 (en) | Human antibodies to influenza hemagglutinin | |
| MA38161A1 (en) | Anti-bmp-6 Antibody | |
| MX378749B (en) | AGENTS FOR INFLUENZA NEUTRALIZATION. | |
| WO2018094300A8 (en) | Anti-gitr antigen-binding proteins and methods of use thereof | |
| WO2020106358A8 (en) | Novel anti-zika virus antibodies and uses thereof | |
| JO3565B1 (en) | Angiopoietin-like 4 antibodies and methods of use | |
| FR2984750B1 (en) | NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING A HUMAN RECEPTOR ANTIBODY OF ANTI-MULLERIAN HORMONE TYPE II |